Pages that link to "Q34295348"

The following pages link to Oxytocin antagonists: clinical and scientific considerations. (Q34295348):

Displaying 12 items.

• Inflammatory aetiology of human myometrial activation tested using directed graphs (Q24813232) (← links)
• A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway (Q34055922) (← links)
• Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus (Q34777113) (← links)
• Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist (Q35545067) (← links)
• Oxytocin: its mechanism of action and receptor signalling in the myometrium (Q38216874) (← links)
• Myometrial response to neurotropic and musculotropic spasmolytic drugs in an extracorporeal perfusion model of swine uteri (Q39728677) (← links)
• Molecular changes induced by repeated restraint stress in the heart: the effect of oxytocin receptor antagonist atosiban. (Q40590558) (← links)
• Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives (Q43981490) (← links)
• Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women (Q45233376) (← links)
• The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism (Q45261068) (← links)
• Non-cardiogenic lung edema in a woman treated with atosiban for preterm labor (Q46498261) (← links)
• Effects of the Oral Oxytocin Receptor Antagonist Tocolytic OBE001 on Reproduction in Rats (Q50980255) (← links)